Literature DB >> 6734427

Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion.

G C Wagner, J Gardner, D J Tsigas, D B Masters.   

Abstract

The tolerance which develops following the repeated administration of phencyclidine has been attributed to both pharmacological and behavioral adaptations. In the present study, the possibility that neurochemical alterations induced by the repeated administration of phencyclidine might account for some portion of the observed tolerance was examined. Specifically, it was postulated that the repeated administration of high doses of phencyclidine might result in long lasting depletion of central catecholamine stores and that this neurochemical perturbation might result in tolerance to the drug's effects. It was observed that phencyclidine disrupted the performance of rats on a fixed-interval schedule maintained by water presentation. The repeated administration of high doses of phencyclidine (but not of a comparable volume of saline) during a period when subjects were not engaged in the fixed-interval task resulted in the development of a long lasting tolerance, but this tolerance could not be accounted for in terms of a depletion of central catecholamine stores.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734427     DOI: 10.1016/0376-8716(84)90063-2

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  Increased sensitivity of mice to tremorogenic agents following MPP+.

Authors:  G C Wagner; S L Walsh
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Functional consequences following methamphetamine-induced neuronal damage.

Authors:  M J De Vito; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Astrocytes as a primary locus for the conversion MPTP into MPP+.

Authors:  W J Brooks; M F Jarvis; G C Wagner
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  L-dopa reverses the effects of MPP+ toxicity.

Authors:  G C Wagner; M F Jarvis; J G Rubin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker.

Authors:  W J Brooks; M F Jarvis; G C Wagner
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.